Global Coagulation Factor IX Market Insights, Forecast to 2025
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Coagulation Factor IX Quarterly Market Size Analysis
- 2.1 Coagulation Factor IX Business Impact Assessment - COVID-19
- 2.1.1 Global Coagulation Factor IX Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Coagulation Factor IX Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Coagulation Factor IX Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Coagulation Factor IX Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Coagulation Factor IX Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Coagulation Factor IX Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Coagulation Factor IX Market
- 3.5 Key Manufacturers Coagulation Factor IX Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Coagulation Factor IX Segments, By Type
- 4.1 Introduction
- 1.4.1 Coagulation Factor IX (Plasma Derived)
- 1.4.2 Coagulation Factor IX (Recombinant)
- 4.2 By Type, Global Coagulation Factor IX Market Size, 2019-2021
- 4.2.1 By Type, Global Coagulation Factor IX Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Coagulation Factor IX Price, 2020-2021
5 Impact of Covid-19 on Coagulation Factor IX Segments, By Application
- 5.1 Overview
- 5.5.1 Adult
- 5.5.2 Kids
- 5.2 By Application, Global Coagulation Factor IX Market Size, 2019-2021
- 5.2.1 By Application, Global Coagulation Factor IX Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Coagulation Factor IX Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Pfizer
- 7.1.1 Pfizer Business Overview
- 7.1.2 Pfizer Coagulation Factor IX Quarterly Production and Revenue, 2020
- 7.1.3 Pfizer Coagulation Factor IX Product Introduction
- 7.1.4 Pfizer Response to COVID-19 and Related Developments
- 7.2 CSL Behring
- 7.2.1 CSL Behring Business Overview
- 7.2.2 CSL Behring Coagulation Factor IX Quarterly Production and Revenue, 2020
- 7.2.3 CSL Behring Coagulation Factor IX Product Introduction
- 7.2.4 CSL Behring Response to COVID-19 and Related Developments
- 7.3 Grifols
- 7.3.1 Grifols Business Overview
- 7.3.2 Grifols Coagulation Factor IX Quarterly Production and Revenue, 2020
- 7.3.3 Grifols Coagulation Factor IX Product Introduction
- 7.3.4 Grifols Response to COVID-19 and Related Developments
- 7.4 Novo Nordisk
- 7.4.1 Novo Nordisk Business Overview
- 7.4.2 Novo Nordisk Coagulation Factor IX Quarterly Production and Revenue, 2020
- 7.4.3 Novo Nordisk Coagulation Factor IX Product Introduction
- 7.4.4 Novo Nordisk Response to COVID-19 and Related Developments
- 7.5 Bioverativ
- 7.5.1 Bioverativ Business Overview
- 7.5.2 Bioverativ Coagulation Factor IX Quarterly Production and Revenue, 2020
- 7.5.3 Bioverativ Coagulation Factor IX Product Introduction
- 7.5.4 Bioverativ Response to COVID-19 and Related Developments
- 7.6 Sanquin
- 7.6.1 Sanquin Business Overview
- 7.6.2 Sanquin Coagulation Factor IX Quarterly Production and Revenue, 2020
- 7.6.3 Sanquin Coagulation Factor IX Product Introduction
- 7.6.4 Sanquin Response to COVID-19 and Related Developments
- 7.7 Takeda
- 7.7.1 Takeda Business Overview
- 7.7.2 Takeda Coagulation Factor IX Quarterly Production and Revenue, 2020
- 7.7.3 Takeda Coagulation Factor IX Product Introduction
- 7.7.4 Takeda Response to COVID-19 and Related Developments
- 7.8 Baxter
- 7.8.1 Baxter Business Overview
- 7.8.2 Baxter Coagulation Factor IX Quarterly Production and Revenue, 2020
- 7.8.3 Baxter Coagulation Factor IX Product Introduction
- 7.8.4 Baxter Response to COVID-19 and Related Developments
- 7.9 Aptevo
- 7.9.1 Aptevo Business Overview
- 7.9.2 Aptevo Coagulation Factor IX Quarterly Production and Revenue, 2020
- 7.9.3 Aptevo Coagulation Factor IX Product Introduction
- 7.9.4 Aptevo Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Coagulation Factor IX Supply Chain Analysis
- 8.1.1 Coagulation Factor IX Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Coagulation Factor IX Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Coagulation Factor IX Distribution Channels
- 8.2.2 Covid-19 Impact on Coagulation Factor IX Distribution Channels
- 8.2.3 Coagulation Factor IX Distributors
- 8.3 Coagulation Factor IX Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Coagulation Factor IX, including the following market information:
Global Coagulation Factor IX Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Coagulation Factor IX Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Coagulation Factor IX Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Coagulation Factor IX Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Pfizer, CSL Behring, Grifols, Novo Nordisk, Bioverativ, Sanquin, Takeda, Baxter, Aptevo, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Based on the Application:
Adult
Kids